XETRA - Delayed Quote EUR

Apontis Pharma AG (APPH.DE)

Compare
10.20
+0.10
+(0.99%)
At close: January 10 at 5:36:16 PM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-7,495.04
-12,595.52
11,019.64
3,433.37
1,451.01
Investing Cash Flow
-2,525.16
-2,933.71
-2,679.23
-1,773.43
-777.17
Financing Cash Flow
-127.45
5,999.86
-1,835.62
20,121.49
-1.64
End Cash Position
16,155.97
26,815.65
36,345.02
29,840.23
8,058.80
Capital Expenditure
-2,628.31
-3,262.52
-3,277.80
-1,659.94
-729.56
Issuance of Capital Stock
--
--
--
38,000.00
--
Issuance of Debt
--
6,000.00
--
--
--
Repayment of Debt
--
--
--
-12,250.00
--
Repurchase of Capital Stock
--
--
-1,835.62
--
--
Free Cash Flow
-10,123.35
-15,858.04
7,741.84
1,773.43
721.45
12/31/2020 - 5/11/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers